Cefepime Injection Market

Cefepimeis used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics.The explosion of COVID-19 around the world has led to a huge increase in the demand for this solution.

Cefepime Injection Market contains market size and forecasts of Cefepime Injection in global, including the following market information:

• Global Cefepime Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Cefepime Injection Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Cefepime Injection companies in 2021 (%)

The global Cefepime Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

1g/50ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cefepime Injection include Pfizer, B Braun, Baxter, Apotex, Fresenius Kabi, Meitheal Pharmaceuticals, Samson Medical Technologies, Sagent and Sandoz, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cefepime Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cefepime Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cefepime Injection Market Segment Percentages, by Type, 2021 (%)

• 1g/50ml
• 2g/100ml

Global Cefepime Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cefepime Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Cefepime Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cefepime Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Cefepime Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Cefepime Injection revenues share in global market, 2021 (%)
• Key companies Cefepime Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Cefepime Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• B Braun
• Baxter
• Apotex
• Fresenius Kabi
• Meitheal Pharmaceuticals
• Samson Medical Technologies
• Sagent
• Sandoz
• WG Critical Care
• Nanjing Hicin Pharmaceutical
• Luoxin Group
• Guangzhou Baiyunshan Pharmaceutical
• Yuekang Pharmaceutical Group